Cited by 792Alzheimer's disease research and treatmentsMitochondrial Function and PathologyDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction

Open access

Devi, Latha, Prabhu, Badanavalu M., Galati, Domenico F., Avadhani, Narayan G., Anandatheerthavarada, Hindupur K.·2006·The Journal of Neuroscience

DOI 10.1523/jneurosci.1469-06.2006PMC PMC6675337

Open this paper in CoChat — free account Open PDF

Abstract

Mitochondrial dysfunction is one of the major intracellular lesions of Alzheimer's disease (AD). However, the causative factors involved in the mitochondrial dysfunction in human AD are not well understood. Here we report that nonglycosylated full-length and C-terminal truncated amyloid precursor protein (APP) accumulates exclusively in the protein import channels of mitochondria of human AD brains but not in age-matched controls. Furthermore, in AD brains, mitochondrially associated APP formed stable approximately 480 kDa complexes with the translocase of the outer mitochondrial membrane 40 (TOM40) import channel and a super complex of approximately 620 kDa with both mitochondrial TOM40 and the translocase of the inner mitochondrial membrane 23 (TIM23) import channel TIM23 in an "N(in mitochondria)-C(out cytoplasm)" orientation. Accumulation of APP across mitochondrial import channels, which varied with the severity of AD, inhibited the entry of nuclear-encoded cytochrome c oxidase subunits IV and Vb proteins, which was associated with decreased cytochrome c oxidase activity and increased levels of H2O2. Regional distribution of mitochondrial APP showed higher levels in AD-vulnerable brain regions, such as the frontal cortex, hippocampus, and amygdala. Mitochondrial accumulation of APP was also observed in the cholinergic, dopaminergic, GABAergic, and glutamatergic neuronal types in the category III AD brains. The levels of translocationally arrested mitochondrial APP directly correlated with mitochondrial dysfunction. Moreover, apolipoprotein genotype analysis revealed that AD subjects with the E3/E4 alleles had the highest content of mitochondrial APP. Collectively, these results suggest that abnormal accumulation of APP across mitochondrial import channels, causing mitochondrial dysfunction, is a hallmark of human AD pathology.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1523/jneurosci.1469-06.2006

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form
Schägger, H., & von JAGOW, G. (1991) · Analytical Biochemistry · doi:10.1016/0003-2697(91)90094-a · Cited by 2,267
The cholinergic hypothesis of Alzheimer’s disease: A review of progress
Francis, P. T., Palmer, A. M., Snape, M., & Wilcock, G. K. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.2.137 · Cited by 2,198 · cited 1×
“In addition to cholinergic neurons, several other neuronal types, such as dopaminergic, GABAergic, and glutamatergic neurons, have been shown to be affected in the later stages of the pathogenesis of AD (Francis et al., 1999; Francis, 2003).”
Background
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease
HYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice
Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447
Mitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367
Translating cell biology into therapeutic advances in Alzheimer's disease
Selkoe, D. J. (1999) · Nature · doi:10.1038/399a023 · Cited by 1,166
Mitochondria are a direct site of Aβ accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression
Manczak, M., Anekonda, T. S., Henson, E., Park, B. S., Quinn, J., & Reddy, P. H. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl066 · Cited by 1,104
Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease
(1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00057-2 · Cited by 981

Flagged first, then by citations

Show all 62 references

Research works printed but not linked: 2

Dasso M (1998) in Current protocols in cell biology, In vitro reconstitution, eds Bonifacino JS Dasso M Harford JB Lippincot-Schawartz J Yamada KM (Wiley, New York), pp 11.0.1–11.0.2.
Jagannatha Rao, 1999, Trace elements in the cerebrospinal fluid of Alzheimer’s disease, Alzheimers Rep, 2, 333

Sorted by citations

Items 201–300 of 790

Swedish Alzheimer Mutation Induces Mitochondrial Dysfunction Mediated by HSP60 Mislocalization of Amyloid Precursor Protein (APP) and Beta-Amyloid
Walls, K. C., Coskun, P. E., Gallegos-Pérez, J.-L., Zadourian, N., Freude, K., Rasool, S., Blurton-Jones, M. M., Green, K. N., & LaFerla, F. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.365890 · Cited by 95
Mitochondrial DNA and inflammatory diseases
Escames, G., López, L. C., García, J. A., García‐Corzo, L., Ortiz, F., & Acuña-Castroviejo, D. (2011) · Human Genetics · doi:10.1007/s00439-011-1057-y · Cited by 97
Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease
Anandatheerthavarada, H. K., & Devi, L. (2007) · The Neuroscientist · doi:10.1177/1073858407303536 · Cited by 95
Is Alzheimer's Disease a Disorder of Mitochondria-Associated Membranes?
Schon, E. A., & Área-Gómez, E. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100495 · Cited by 98
Synergistic Protective Effects of Mitochondrial Division Inhibitor 1 and Mitochondria-Targeted Small Peptide SS31 in Alzheimer’s Disease
Reddy, P. H., Mańczak, M., Yin, X., & Reddy, A. P. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170988 · Cited by 97
Alzheimer’s disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links
Rojas, M., Chávez-Castillo, M., Bautista, J., Ortega, Á., Nava, M., Salazar, J. J., Díaz-Camargo, E. A., Medina, O., Rojas, J., & Bermúdez, V. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i6.745 · Cited by 98
Disentangling Mitochondria in Alzheimer’s Disease
Johri, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111520 · Cited by 103
Genetics of Alzheimer’s Disease
Ridge, P. G., Ebbert, M., & Kauwe, J. S. K. (2013) · BioMed Research International · doi:10.1155/2013/254954 · Cited by 104
Mitochondria-Targeted Protective Compounds in Parkinson’s and Alzheimer’s Diseases
Fernández‐Moriano, C., González‐Burgos, E., & Gómez-Serranillos, M. P. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/408927 · Cited by 100
Interaction between NH2-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration
Amadoro, G., Corsetti, V., Atlante, A., Florenzano, F., Capsoni, S., Bussani, R., Mercanti, D., & Calissano, P. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.08.001 · Cited by 95
Protein homeostasis of a metastable subproteome associated with Alzheimer’s disease
Kundra, R., Ciryam, P., Morimoto, R. I., Dobson, C. M., & Vendruscolo, M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618417114 · Cited by 93
Protein interaction networks in neurodegenerative diseases: From physiological function to aggregation
Calabrese, G., Molzahn, C. M., & Mayor, T. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102062 · Cited by 92
Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease
Austad, S. N., Ballinger, S. W., Buford, T. W., Carter, C. S., Smith, D. L., Darley-Usmar, V. M., & Zhang, J. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.06.014 · Cited by 94
Aβ accumulation in choroid plexus is associated with mitochondrial-induced apoptosis
Vargas, T., Ugalde, C., Spuch, C., Antequera, D., Morán, M., Martín, M. A., Ferrer, I., Bermejo‐Pareja, F., & Carro, E. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.08.017 · Cited by 93
Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice
Xu, Y., Xu, K., Sun, Y., Liou, B., Quinn, B., Li, R.-H., Xue, L., Zhang, W., Setchell, K. D. R., Witte, D. P., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu105 · Cited by 88
Ginsenoside Re Inhibits ROS/ASK-1 Dependent Mitochondrial Apoptosis Pathway and Activation of Nrf2-Antioxidant Response in Beta-Amyloid-Challenged SH-SY5Y Cells
Liu, M., Bai, X., Yu, S., Zhao, W., Qiao, J., Liu, Y., Zhao, D., Wang, J., & Wang, S. (2019) · Molecules · doi:10.3390/molecules24152687 · Cited by 89
Physical exercise during exposure to 40-Hz light flicker improves cognitive functions in the 3xTg mouse model of Alzheimer’s disease
Park, S.-S., Park, H.-S., Kim, C., Kang, H., Kim, D., Baek, S., & Kim, T.-W. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00631-4 · Cited by 94
The Novel Role of Mitochondrial Citrate Synthase and Citrate in the Pathophysiology of Alzheimer’s Disease
Chhimpa, N., Singh, N., Puri, N., & Kayath, H. P. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-220514 · Cited by 89
The early events of Alzheimer's disease pathology: from mitochondrial dysfunction to BDNF axonal transport deficits
Ye, X., Tai, W., & Zhang, D. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.11.004 · Cited by 90
Exercise as a Positive Modulator of Brain Function
Alkadhi, K. A. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0516-4 · Cited by 93
Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?
Reddy, P. H. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.09.003 · Cited by 88
Axonal Transport Defects in Alzheimer’s Disease
Wang, Z., Tan, L., & Yu, J. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8810-x · Cited by 92
Mitochondrial Dysfunction
Leuner, K., Stockburger, C., Denzer, I., Eckert, G. P., & Müller, W. E. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394625-6.00007-6 · Cited by 89
The mitochondrial hypothesis: Dysfunction, bioenergetic defects, and the metabolic link to Alzheimer's disease
Swerdlow, R. H. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.01.008 · Cited by 88
Human and rodent amyloid-β peptides differentially bind heme: Relevance to the human susceptibility to Alzheimer’s disease
Atamna, H., Frey, W. H., & Ko, N. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.05.003 · Cited by 88
Neurometabolites and associations with cognitive deficits in mild cognitive impairment: a magnetic resonance spectroscopy study at 7 Tesla
Oeltzschner, G., Wijtenburg, S. A., Mikkelsen, M. E., Edden, R. A. E., Barker, P. B., Joo, J. H., Leoutsakos, J., Rowland, L. M., Workman, C. I., & Smith, G. S. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.09.027 · Cited by 83
Integrating Gene and Protein Expression Reveals Perturbed Functional Networks in Alzheimer’s Disease
Canchi, S., Raao, B., Masliah, D., Rosenthal, S. B., Šášik, R., Fisch, K. M., Jager, P. L. D., Bennett, D. A., & Rissman, R. A. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.073 · Cited by 82
Protective Effect of Isorhynchophylline Against β-Amyloid-Induced Neurotoxicity in PC12 Cells
Xian, Y., Lin, Z., Mao, Q., Ip, S., Su, Z., & Lai, X. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9763-5 · Cited by 84
Modes of Aβ toxicity in Alzheimer’s disease
Götz, J., Eckert, A., Matamales, M., Ittner, L. M., & Liu, X. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0750-2 · Cited by 87
Functions of amyloid precursor protein in metabolic diseases
Guo, Y., Wang, Q., Chen, S., & Xu, C. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154454 · Cited by 89
How the Wnt signaling pathway protects from neurodegeneration: the mitochondrial scenario
Arrázola, M. S., Silva-Álvarez, C., & Inestrosa, N. C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00166 · Cited by 80
Mitochondrial accumulation of APP and Aβ: significance for Alzheimer disease pathogenesis
Pavlov, P. F., Petersen, C. H., Glaser, E. G., & Ankarcrona, M. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00892.x · Cited by 84
The protective role of plant biophenols in mechanisms of Alzheimer's disease
Omar, S. H., Scott, C., Hamlin, A. S., & Obied, H. K. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.02.016 · Cited by 84
Enhanced derivation of human pluripotent stem cell-derived cortical glutamatergic neurons by a small molecule
Cao, S.-Y., Hu, Y. F., Chen, C. Y., Yuan, F., Xu, M., Li, Q., Fang, K.-H., Chen, Y., & Liu, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-03519-w · Cited by 84
Proteinopathies and OXPHOS dysfunction in neurodegenerative diseases
Kawamata, H., & Manfredi, G. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201709172 · Cited by 86
The Alzheimer’s Disease Mitochondrial Cascade Hypothesis: A Current Overview
Swerdlow, R. H. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221286 · Cited by 88
Neurotoxic β-amyloid oligomers cause mitochondrial dysfunction—the trigger for PANoptosis in neurons
Meng, X., Song, Q., Liu, Z., Liu, X., Wang, Y., & Liu, J. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1400544 · Cited by 84
Mitochondrial biology in Alzheimer’s disease pathogenesis
Galindo, M. F., Ikuta, I., Zhu, X., Casadesús, G., & Jordán, J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06814.x · Cited by 79
Protection against amyloid beta cytotoxicity by sulforaphane: Role of the proteasome
Park, H.-M., Kim, J., & Kwak, M. (2009) · Archives of Pharmacal Research · doi:10.1007/s12272-009-1124-2 · Cited by 79
Chronic exposure to sub‐lethal beta‐amyloid (Aβ) inhibits the import of nuclear‐encoded proteins to mitochondria in differentiated PC12 cells*
Sirk, D. P., Zhu, Z., Wadia, J. S., Shulyakova, N., Phan, N., Fong, J. C., & Mills, L. R. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04907.x · Cited by 81
Journal of Parkinson’s disease & Alzheimer’s disease
Gottschalk, W. K., Lutz, M. W., He, Y. T., Saunders, A. M., Burns, D. K., Roses, A. D., & Chiba‐Falek, O. (2014) · Journal of Parkinson’s Disease and Alzheimer’s Disease · doi:10.13188/2376-922x.1000003 · Cited by 80
Ubiquitin-dependent mitochondrial protein degradation
Heo, J.-M., & Rutter, J. P. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.06.002 · Cited by 76
Warning SINEs: Alu elements, evolution of the human brain, and the spectrum of neurological disease
Larsen, P. A., Hunnicutt, K. E., Larsen, R. J., Yoder, A. D., & Saunders, A. M. (2018) · Chromosome Research · doi:10.1007/s10577-018-9573-4 · Cited by 79
A novel high-throughput assay for respiration in isolated brain microvessels reveals impaired mitochondrial function in the aged mice
Sure, V. N. L. R., Sakamuri, S. S. V. P., Sperling, J. A., Evans, W. R., Merdžo, I., Mostany, R., Murfee, W. L., Busija, D. W., & Katakam, P. V. G. (2018) · GeroScience · doi:10.1007/s11357-018-0037-8 · Cited by 78
Spotlight on Ferroptosis: Iron-Dependent Cell Death in Alzheimer’s Disease
Ashraf, A., & So, P. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00196 · Cited by 76
Exendin-4 attenuates brain mitochondrial toxicity through PI3K/Akt-dependent pathway in amyloid beta (1–42)-induced cognitive deficit rats
Garabadu, D., & Verma, J. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.04.006 · Cited by 75
The Bewildering Effect of AMPK Activators in Alzheimer’s Disease: Review of the Current Evidence
Assefa, B. T., Tafere, G. G., Wondafrash, D. Z., & Gidey, M. T. (2020) · BioMed Research International · doi:10.1155/2020/9895121 · Cited by 76
Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer’s Disease
Torres, A. K., Jara, C., Park-Kang, H. S., Polanco, C. M., Tapia, D., Alarcón, F., de la Peña, A., Llanquinao, J., Vargas-Mardones, G., Álvarez‐Indo, J., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215139 · Cited by 80
Protective Effects of Hesperidin Against Amyloid-β (Aβ) Induced Neurotoxicity Through the Voltage Dependent Anion Channel 1 (VDAC1)-Mediated Mitochondrial Apoptotic Pathway in PC12 Cells
Wang, D., Li, S., Zhu, X., Wang, Y., Wu, W., & Zhang, X. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1013-4 · Cited by 75
Cytochrome c Oxidase and Its Role in Neurodegeneration and Neuroprotection
Arnold, S. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3573-0_13 · Cited by 77
Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels
Bekris, L. M., Millard, S. P., Galloway, N. M., Vuletic, S., Albers, J. J., Li, G., Galasko, D. R., DeCarli, C., Farlow, M. R., Clark, C. M., et al. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-13303 · Cited by 85
Mitochondria-associated membranes (MAMs): a potential therapeutic target for treating Alzheimer’s disease
Yu, W., Jin, H., & Huang, Y. (2021) · Clinical Science · doi:10.1042/cs20200844 · Cited by 75
Structure‐Based Design and Synthesis of Benzothiazole Phosphonate Analogues with Inhibitors of Human ABAD‐Aβ for Treatment of Alzheimer’s Disease
Valasani, K. R., Hu, G., Chaney, M. O., & Yan, S. S. (2012) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12068 · Cited by 75
Mitochondrial dysfunction and beneficial effects of mitochondria-targeted small peptide SS-31 in Diabetes Mellitus and Alzheimer’s disease
Ding, X.-W., Robinson, M., Li, R., Aldhowayan, H., Geetha, T., & Babu, J. R. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105783 · Cited by 73
Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer’s Disease
Calkins, M. J., Mańczak, M., & Reddy, P. (2012) · Pharmaceuticals · doi:10.3390/ph5101103 · Cited by 71
Construction and analysis of the protein-protein interaction networks for schizophrenia, bipolar disorder, and major depression
Lee, S., Tsao, T. T.-H., Yang, K.-C., Lin, H., Kuo, Y.-L., Hsu, C.-H., Lee, W., Huang, K.-C., & Kao, C. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-s13-s20 · Cited by 72
Functionalized nanosystems for targeted mitochondrial delivery
Durazo, S. A., & Kompella, U. B. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.11.001 · Cited by 73
Epoxyeicosatrienoic acids pretreatment improves amyloid β-induced mitochondrial dysfunction in cultured rat hippocampal astrocytes
Sarkar, P., Žaja, I., Bienengraeber, M., Rarick, K. R., Terashvili, M., Canfield, S. G., Falck, J. R., & Harder, D. R. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00001.2013 · Cited by 72
Huntingtin protein is essential for mitochondrial metabolism, bioenergetics and structure in murine embryonic stem cells
Ismailoglu, I., Chen, Q., Popowski, M., Yang, L., Gross, S. S., & Brivanlou, A. H. (2014) · Developmental Biology · doi:10.1016/j.ydbio.2014.04.005 · Cited by 72
The Alu neurodegeneration hypothesis: A primate‐specific mechanism for neuronal transcription noise, mitochondrial dysfunction, and manifestation of neurodegenerative disease
Larsen, P. A., Lutz, M. W., Hunnicutt, K. E., Mihovilovic, M., Saunders, A. M., Yoder, A. D., & Roses, A. D. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.01.017 · Cited by 74
Reduced VDAC1 Protects Against Alzheimer's Disease, Mitochondria, and Synaptic Deficiencies
Mańczak, M., Sheiko, T. V., Craigen, W. J., & Reddy, P. H. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130761 · Cited by 73
Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936
Lyall, D. M., Harris, S. E., Bastin, M. E., Maniega, S. M., Murray, C. L., Lutz, M. W., Saunders, A. M., Roses, A. D., Hernández, M. D. C. V., Royle, N. A., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.006 · Cited by 70
Progress in drug development for Alzheimer's disease: An overview in relation to mitochondrial energy metabolism
Hroudová, J., Singh, N., Fišar, Z., & Ghosh, K. K. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.03.084 · Cited by 71
RETRACTED: Aqua-soluble DDQ reduces the levels of Drp1 and A β and inhibits abnormal interactions between A β and Drp1 and protects Alzheimer’s disease neurons from A β - and Drp1-induced mitochondrial and synaptic toxicities
Kuruva, C. S., Mańczak, M., Yin, X., Ogunmokun, G., Reddy, A. P., & Reddy, P. H. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx226 · Cited by 71
Retracted
Nrf2 activation through the PI3K/GSK-3 axis protects neuronal cells from Aβ-mediated oxidative and metabolic damage
Sotolongo, K., Ghiso, J. A., & Rostagno, A. A. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0578-9 · Cited by 74
Longitudinal modeling of cognitive aging and the TOMM40 effect
Caselli, R. J., Dueck, A. C., Huentelman, M. J., Lutz, M. W., Saunders, A. M., Reiman, E. M., & Roses, A. D. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.11.006 · Cited by 69
“Other aggregating proteins, including amyloid precursor protein, accumulate in these pores, also contributing to mitochondrial dysfunction [9].”
Background
Mitochondrial Abnormalities and Synaptic Loss Underlie Memory Deficits Seen in Mouse Models of Obesity and Alzheimer’s Disease
Martins, I. V. A., Rivers‐Auty, J., Allan, S. M., & Lawrence, C. B. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160640 · Cited by 70
Potential Therapeutic Role of Phytochemicals to Mitigate Mitochondrial Dysfunctions in Alzheimer’s Disease
Rahman, M. A., Rahman, M. H., Biswas, P., Hossain, M. S., Islam, R., Hannan, M. A., Uddin, M. J., & Rhim, H. (2020) · Antioxidants · doi:10.3390/antiox10010023 · Cited by 71
The protective effect of hyperbaric oxygen and Ginkgo biloba extract on A?25?35-induced oxidative stress and neuronal apoptosis in rats
Tian, X., Zhang, L., Wang, J., Dai, J., Shen, S., Yang, L., & Huang, P. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.12.026 · Cited by 70
Epigenetic signature and enhancer activity of the human APOE gene
Yu, C., Cudaback, E., Foraker, J. E., Thomson, Z., Leong, L., Lutz, F., Gill, J. A., Saxton, A. D., Kraemer, B. C., Navas, P. A., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt354 · Cited by 71
Clinical Features and Pathogenesis of Alzheimer’s Disease: Involvement of Mitochondria and Mitochondrial DNA
Mancuso, M., Orsucci, D., LoGerfo, A., Calsolaro, V., & Siciliano, G. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6448-9_4 · Cited by 69
Mechanisms Linking Mitochondrial Dysfunction and Proteostasis Failure
Lu, B., & Guo, S. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.01.008 · Cited by 69
Natural products targeting mitochondria: emerging therapeutics for age-associated neurological disorders
Liang, Z., Currais, A. J. M., Soriano‐Castell, D., Schubert, D. A., & Maher, P. A. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107749 · Cited by 71
Down-regulation of Mortalin Exacerbates Aβ-mediated Mitochondrial Fragmentation and Dysfunction
Park, S. J., Shin, J. H., Jeong, J. I., Song, J. H., Jo, Y. K., Kim, E. S., Lee, E. H., Hwang, J. J., Lee, E. K., Chung, S. J., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.492587 · Cited by 71
Appoptosin is a Novel Pro-Apoptotic Protein and Mediates Cell Death in Neurodegeneration
Zhang, H., Zhang, Y.-W., Chen, Y., Huang, X., Zhou, F., Wang, W., Xian, B., Zhang, X., Masliah, E., Chen, Q., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.3668-12.2012 · Cited by 68
Dysfunction of mitochondria: Implications for Alzheimer's disease
Albensi, B. C. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.03.001 · Cited by 68
Dysregulation of amyloid precursor protein impairs adipose tissue mitochondrial function and promotes obesity
An, Y., Crewe, C., Asterholm, I. W., Sun, K., Chen, S., Zhang, F., Shao, M., Funcke, J., Zhang, Z., Straub, L. G., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0149-1 · Cited by 64
Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Sensitivity, Specificity and Potential for Clinical Use
d’Abramo, C., D'adamio, L., & Giliberto, L. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030116 · Cited by 71
Mitochondrial dynamics and mitochondrial autophagy: Molecular structure, orchestrating mechanism and related disorders
Wang, H., Luo, W., Chen, H., Cai, Z., & Xu, G. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101847 · Cited by 70
Kynurenines, neurodegeneration and Alzheimer’s disease
Kincses, Z. T., Toldi, J., & Vécsei, L. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01123.x · Cited by 70
Peptides as Potential Therapeutics for Alzheimer’s Disease
Ribarič, S. (2018) · Molecules · doi:10.3390/molecules23020283 · Cited by 69
Pyruvate Dehydrogenase Kinases in the Nervous System: Their Principal Functions in Neuronal-glial Metabolic Interaction and Neuro-metabolic Disorders
Jha, M. K., Jeon, S., & Suk, K. (2012) · Current Neuropharmacology · doi:10.2174/157015912804143586 · Cited by 71
The consequences of mitochondrial amyloid β-peptide in Alzheimer's disease
Muirhead, K. E. A., Borger, E., Aitken, L., Conway, S. J., & Gunn‐Moore, F. J. (2010) · Biochemical Journal · doi:10.1042/bj20091941 · Cited by 68
Dysfunctional mitochondria in age-related neurodegeneration: Utility of melatonin as an antioxidant treatment
Reiter, R. J., Sharma, R., Manucha, W. A., Rosales‐Corral, S., Chuffa, L. G. D. A., Loh, D., Luchetti, F., Balduini, W., & Govitrapong, P. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102480 · Cited by 75
Heterogeneity of nervous system mitochondria: Location, location, location!
Dubinsky, J. M. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.05.020 · Cited by 67
Blood‐Based Bioenergetic Profiling Reflects Differences in Brain Bioenergetics and Metabolism
Tyrrell, D. J., Bharadwaj, M. S., Jorgensen, M. J., Register, T. C., Shively, C. A., Andrews, R. N., Neth, B. J., Keene, C. D., Mintz, A., Craft, S., et al. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/7317251 · Cited by 66
Evaluation of late-onset Alzheimer disease genetic susceptibility risks in a Canadian population
Omoumi, A., Fok, A., Greenwood, T., Sadovnick, A. D., Feldman, H., & Hsiung, G. R. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.025 · Cited by 64
Emerging perspectives on mitochondrial dysfunction and inflammation in Alzheimer’s disease
Yoo, S., Park, J., Kim, S., & Jung, Y. (2020) · BMB Reports · doi:10.5483/bmbrep.2020.53.1.274 · Cited by 65
Newly Developed Drugs for Alzheimer’s Disease in Relation to Energy Metabolism, Cholinergic and Monoaminergic Neurotransmission
Korábečný, J., Nepovimová, E., Cikánková, T., Špilovská, K., Vašková, L., Mezeiová, E., Kuča, K., & Hroudová, J. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2017.06.034 · Cited by 64
Mitochondrial Importance in Alzheimer’s, Huntington’s and Parkinson’s Diseases
Correia, S. C., Santos, R. X., Perry, G. L., Zhu, X., Moreira, P. I., & Smith, M. A. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0653-2_16 · Cited by 65
RETRACTED: Cytoplasmic gelsolin increases mitochondrial activity and reduces Aβ burden in a mouse model of Alzheimer's disease
Antequera, D., Vargas, T., Ugalde, C., Spuch, C., Molina, J. A., Ferrer, I., Bermejo‐Pareja, F., & Carro, E. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.06.018 · Cited by 64
Retracted
Long non-coding RNAs in brain development, synaptic biology, and Alzheimer’s disease
Shi, C., Zhang, L., & Qin, C. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.03.010 · Cited by 65
Pyruvate Dehydrogenase Kinases in the Nervous System: Their Principal Functions in Neuronal-glial Metabolic Interaction and Neuro-metabolic Disorders
Jha, M. K., Jeon, S., & Suk, K. (2012) · Current Neuropharmacology · doi:10.2174/157015912804499528 · Cited by 64
The Cause of Alzheimer’s Disease: The Theory of Multipathology Convergence to Chronic Neuronal Stress
Decourt, B., D’Souza, G. X., Shi, J., Ritter, A., Suazo, J., & Sabbagh, M. N. (2022) · Aging and disease · doi:10.14336/ad.2021.0529 · Cited by 69
Mitochondria Transfer in Brain Injury and Disease
Fairley, L. H., Grimm, A., & Eckert, A. (2022) · Cells · doi:10.3390/cells11223603 · Cited by 63
APOE mRNA and protein expression in postmortem brain are modulated by an extended haplotype structure
Bekris, L. M., Galloway, N. M., Montine, T. J., Schellenberg, G. D., & Yu, C. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30993 · Cited by 63
Age related mitochondrial degenerative disorders in humans
Reeve, A. K., Krishnan, K. J., & Turnbull, D. M. (2008) · Biotechnology Journal · doi:10.1002/biot.200800066 · Cited by 66
A Role for SERCA Pumps in the Neurobiology of Neuropsychiatric and Neurodegenerative Disorders
Britzolaki, A., Saurine, J., Klocke, B., & Pitychoutis, P. M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12457-1_6 · Cited by 63
Assessment of newly synthesized mitochondrial DNA using BrdU labeling in primary neurons from Alzheimer's disease mice: Implications for impaired mitochondrial biogenesis and synaptic damage
Calkins, M. J., & Reddy, P. H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.04.006 · Cited by 65
Altered synapses in a Drosophila model of Alzheimer's disease
Mhatre, S. D., Satyasi, V., Killen, M., Paddock, B. E., Moir, R. D., Saunders, A. J., & Marenda, D. R. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.012104 · Cited by 70

Authors: Devi, L., Prabhu, B. M., Galati, D. F., Avadhani, N. G., & Anandatheerthavarada, H. K.
Affiliations: University of Pennsylvania (US)
ORCID: Galati, Domenico F.
Avadhani, Narayan G.
Venue: The Journal of Neuroscience
Publisher: Society for Neuroscience
Published: 2006-08-30
Volume: 26
Issue: 35
Pages: 9057-9068
ISSN: 0270-6474 (ISSN-L)
1529-2401
DOI: 10.1523/jneurosci.1469-06.2006
PMC: PMC6675337
OpenAlex: W2076241970
Cited by: 792
References: 62
Citations by year: 2026: 21 · 2025: 21 · 2024: 36 · 2023: 47 · 2022: 53 · 2021: 60 · 2020: 50 · 2019: 37 · 2018: 44 · 2017: 39 · 2016: 36 · 2015: 35 · 2014: 34 · 2013: 40 · 2012: 50
FWCI: 19.78
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-sa
creativecommons.org/licenses/by-nc-sa/4.0/ (vor, 182 d)
Locations: Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
National Institute on Aging (R01AG021920, AG 021920)
National Institute of General Medical Sciences (GM-49683, R01GM049683)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: amyloid precursor protein, Alzheimer's disease, mitochondrial dysfunction, Tom40, Tim23, cytochrome c oxidase, hydrogen peroxide, neuronal cell types
MeSH terms: Alzheimer Disease, Apolipoproteins E, Biological Transport, Brain, Cadaver, Electron Transport Complex IV, Glycosylation, Humans, Hydrogen Peroxide, Mitochondria, Neurons, Tissue Distribution, Case-Control Studies, Amyloid beta-Protein Precursor, Mitochondrial Proteins, Mitochondrial Membrane Transport Proteins, Mitochondrial Membranes, Apolipoprotein E3, Apolipoprotein E4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks